Brunei vs Luxembourg: Cause of death, by non-communicable diseases, ages 5-14
Brunei
73.4%
in 2021
Luxembourg
76.4%
in 2021
Brunei rank
4th
Luxembourg rank
2nd
Cause of death, by non-communicable diseases, ages 5-14 over time
- Brunei
- Luxembourg
How they compare
Luxembourg currently reports 76.4% against 73.4% in Brunei, a difference of 3.0%.
The two have swapped places 4 times across 6 shared years of data; in 2000 it was Luxembourg ahead.
Brunei ranks 4th and Luxembourg ranks 2nd of 185 countries.
Across the 3 decades both report, Brunei averaged higher in 1 and Luxembourg in 2.
Head to head by decade
| Decade | Brunei | Luxembourg | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 40.4% | 47.5% | 7.1% | Luxembourg |
| 2010s | 65.9% | 53.1% | 12.8% | Brunei |
| 2020s | 73.1% | 76.6% | 3.5% | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Brunei or Luxembourg?
- Luxembourg, at 76.4% against 73.4% in Brunei as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Brunei and Luxembourg?
- 3.0%, with Luxembourg ahead.
- How many years of comparable data are there for Brunei and Luxembourg?
- 6 years are reported by both, from 2000 to 2021.
- How do Brunei and Luxembourg rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Brunei ranks 4th and Luxembourg ranks 2nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.